Skip to Main Content
Back to News

New Analyst Forecast: $MURA Given 'Outperform' Rating

None

We just received data on a new analyst forecast for $MURA. Raymond James gave a rating of 'Outperform' for $MURA.

$MURA Analyst Ratings

Wall Street analysts have issued reports on $MURA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Raymond James issued a "Outperform" rating on 03/25/2025
  • H.C. Wainwright issued a "Buy" rating on 10/17/2024

To track analyst ratings and price targets for $MURA, check out Quiver Quantitative's $MURA forecast page.

$MURA Insider Trading Activity

$MURA insiders have traded $MURA stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $MURA stock by insiders over the last 6 months:

  • VICKI L GOODMAN (Chief Medical Officer) has made 0 purchases and 2 sales selling 18,255 shares for an estimated $68,173.
  • ADAM D. CUTLER (Chief Financial Officer) sold 7,421 shares for an estimated $25,305
  • CAROLINE LOEW (Chief Executive Officer) has made 0 purchases and 2 sales selling 7,076 shares for an estimated $23,885.
  • MAIKEN KESON-BROOKES (See Remarks) has made 0 purchases and 3 sales selling 5,286 shares for an estimated $17,663.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MURA Hedge Fund Activity

We have seen 25 institutional investors add shares of $MURA stock to their portfolio, and 49 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles